No Data
Hualan Biological Engineering, Inc. (002007.SZ): The company has a total of 34 blood plasma collection stations (including 6 branch stations).
On April 14, Glonghui reported that Hualan Biological Engineering, Inc. (002007.SZ) stated on the investor interaction platform that the company has a total of 34 single-plasma collection stations (including 6 branch stations). In 2024, the total plasma collection volume will be 1,586.37 tons, an increase of 18.18% compared to the previous year.
These Analysts Just Made A Meaningful Downgrade To Their Hualan Biological Engineering Inc. (SZSE:002007) EPS Forecasts
Hualan Biological Engineering Inc. Just Missed EPS By 19%: Here's What Analysts Think Will Happen Next
Hualan Biology: 2024 Annual Report
Hualan Biology: 2024 Annual Report Summary
Hualan Biological Engineering, Inc. (002007.SZ): The net income attributable to the parent company for the year 2024 is 1.088 billion yuan, proposing a dividend of 2 yuan per share.
Gelonghui, March 28 - Hualan Biological Engineering, Inc. (002007.SZ) announced its 2024 annual report, achieving revenue of 4.379 billion yuan in 2024, a year-on-year decrease of 18.02%; net income attributable to shareholders of the listed company was 1.088 billion yuan, a year-on-year decrease of 26.57%; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 0.981 billion yuan, a year-on-year decrease of 22.56%; the basic EPS was 0.5958 yuan; it plans to distribute a cash dividend of 2 yuan (including tax) for every 10 shares to all shareholders.
Some Confidence Is Lacking In Hualan Biological Engineering Inc.'s (SZSE:002007) P/E
